International Mentored Scientist Award

Spring 2024 funding cycle: Applications closed, funding results available before end of May 2024

Fall 2024 funding cycle:

  • Call opens: Thursday, August 29, 2024
  • Deadline: Monday September 30, 2024 (2:00 pm PST)
  • Funding Results: available before end of December, 2024

Amount available: $30,000 in direct costs for 1 year

Apply through the UCSF Resource Allocation Program (RAP) portal

The International Mentored Scientist Award seeks to provide a mentored career development opportunity in HIV research for international investigators affiliated with UCSF. Applicants for this award must indicate a UCSF-affiliated faculty research mentor(s) in HIV who will commit to guiding the applicant for the application process and throughout the duration of the proposed project. Project proposals should be geared toward the interests of the applicant (e.g., clinical, basic, implementation science and/or behavioral-epidemiological research) and focus on HIV research in the investigator’s home country.

Eligibility
Researchers (all levels), post-doctoral fellows, and trainees located at a UCSF-affiliated foreign institution who have not received an NIH R01- equivalent grant in HIV/AIDS are eligible. Please note that CFAR is not allowed to provide funding to any investigators who have received HIV-related R01 awards. More senior faculty members may apply only if they are newly entering the field of HIV research.

Designation of Mentor (Critical)

Mentoring is critical to the training component of the CFAR International Mentored Scientist awards. All International Mentored award applications require a faculty research mentor from UCSF or a UCSF-affiliated institution (https://cfar.ucsf.edu/about/partners). Applications without a mentor will be disqualified.

Applicants must identify their UCSF-affiliated mentors and arrange to receive mentor advice and guidance on the research portion of their application well before it is submitted (typically at least two months before the RAP deadline). CFAR is no longer available to assist with mentor identification.

Projects must be within NIH’s HIV/AIDS research high or medium priority areas. Projects in closely related areas (e.g. TB, HCV, drug use, etc.) must be clearly linked to HIV in order to be eligible for CFAR funding.

The award amount is $30,000 in direct costs for one year.
For more detailed information about this RFA, please see the RAP Portal.

International Mentored Science Awardees

36 Awards

Award Recipient Award date Award Type
The Accuracy of Clinical TB Diagnoses among HIV positive and negative individuals in Zambia: Alternative Diagnoses, Treatment Outcomes, and Decision-Making Factors Mary Kagujje, MBChB, MSc Spring International Mentored Scientist Award
Assessment of chronic kidney disease and its progression among older people living with HIV in Uganda Judith Amutuhaire Ssemasaazi, MD Spring International Mentored Scientist Award
“For Us by Us:” A Peer-led Community-Informed Exploratory Study to Increase HIV-Self Testing and PrEP Uptake Among Men who have Sex with Men in Nairobi, Kenya Maureen Akolo, RN, PhD Spring International Mentored Scientist Award
Potential for Xpert MTB/RIF Ultra cycle threshold values to monitor early response to anti-TB treatment in HIV co-infected patients on antiretroviral therapy Juliet Namugenyi, MSc Spring International Mentored Scientist Award
Prevalence and outcomes associated with SARS-COV-2 antibody seropositivity among persons at risk for tuberculosis in a high HIV-burden setting: a cohort study in Lusaka, Zambia Nsala Sanjase, MBChB Spring International Mentored Scientist Award
Prevalence, clinical and immunological predictors of frailty among older adults with HIV in Kampala Phoebe Mbabazi, MD Fall International Mentored Scientist Award
Adaptation of a Mindfulness based intervention to support Adherence to Antiretroviral Therapy among adolescents in Uganda Khamisi Musanje, M.A. Fall International Mentored Scientist Award
Willingness and Feasibility of Using Injectable Antiretroviral Therapy among Women who Retained and Disengaged from Prevention of Mother to Child HIV Transmission Programs in Uganda Deborah Ekusai-Sebatta, PhD Spring International Mentored Scientist Award
Changes in insulin kinetics in HIV infected patients diagnosed with dolutegravir associated diabetes in Uganda Frank Mulindwa, MD Fall International Mentored Scientist Award
Impact Evaluation of a Primary Care Health System Strengthening Intervention on HIV and TB services in Kono and Kailahun Districts, Sierra Leone Mohamed Bailor Barrie, MD, PhD (Cand) Spring International Mentored Scientist Award
Investigating into the social, health and economic vulnerabilities and resilience of children of women at high risk of HIV in Kampala Agnes Ssali, PhD Fall International Mentored Scientist Award
Effect of human immunodeficiency virus type 1 (HIV-1) subtype C transactivator of transcription (Tat) P21A variant on nuclear levels of active positive transcription elongation factor b (P-TEFb) and viral latency Paradise Madlala, PhD Fall International Mentored Scientist Award
Evaluation of an African specific Donor Health Questionnaire for HIV screening in Cameroonian blood services Claude Tayou-Tagny MCR/MPH/MS, MD, MSC Fall International Mentored Scientist Award
Exploring HIV care of highly mobile HIV-positive youth living in Kenya and Uganda: qualitative study to identify gaps in the HIV care cascade and evaluate feasible intervention options Irene Maeri , BA, MA Spring International Mentored Scientist Award
Testing Medicinal Plants from Uganda for HIV Latency Reversing Activity Emmanuel Mande, Bsc Spring International Mentored Scientist Award
Understanding factors that facilitate effective uptake and integration of health interventions in South African primary health care clinics van Heerden Alastair, PhD Fall International Mentored Scientist Award
Patients and peer navigators lived experiences and drivers for creating a successful personalized adaptive care relationship to treat lapses HIV treatment retention: a longitudinal qualitative study Zachary Kwena, PhD(c), MA Fall International Mentored Scientist Award
Understanding the impact of an income generating agricultural intervention on sexual behaviour and psychological well being of adolescent girls and young women living in a high HIV urban setting in Western Kenya Mariacianah Onono, MD Spring International Mentored Scientist Award
Development and Validation of an HPLC-UV Multiplex Assay for Therapeutic Drug Monitoring of Antiretroviral Drugs in Uganda Allan Buzibye, Bsc Fall International Mentored Scientist Award
ComHealth: Cost-effective mHealth strategy to improve long-term retention in HIV care for mother-baby pairs Thomas Odeny, MBChB, MPH Spring International Mentored Scientist Award
Global gene array, secretome analyses, and HIV infection analyses of foreskin epithelial cells upon exposure to cervicovaginal fluid from healthy vs. women with bacterial vaginosis Grace Turyasingura, BSc Spring International Mentored Scientist Award
Evaluation of a point-of-care assay for the diagnosis of Trichomonas vaginalis in women at high risk for HIV infection Sheila Nabweyambo, BSc Fall International Mentored Scientist Award
Feasibility of Screening and Brief Intervention for Hazardous Alcohol use amongst HIV-infected Adults in Uganda: A Qualitative Study Stephen Asiimwe, MMed, MBChB Spring International Mentored Scientist Award
Impact of Neonatal Exposure to Malaria and HIV on the Frequency, Phenotype, and Function of __ T Cell Subsets at Birth Fredrick Lutwama, PhD, MDChb Spring International Mentored Scientist Award
Promoting Positive Caregiver-Child Interaction Between HIV-Affected Children and Their Caregivers with Depression in Kwa-Zulu Natal, South Africa Duncan Andrew, MA Spring International Mentored Scientist Award
Investigation of Pediatric HIV Disclosure in Kampala, Uganda Monica Etima, MBChB, MMed Spring International Mentored Scientist Award
Mechanisms of CD4 T-cell death among HIV-infected, HAART-treated African adults displaying poor CD4 T-cell reconstitution despite effective viral suppression Damalie Nakanjako, MBChB, MMed, PhD Fall International Mentored Scientist Award
A study to evaluate the acceptability and feasibility of providing integrated HIV and maternal and child health services thorough well child services in KwaZulu Natal, South Africa Christiane Horwood, MBBS Fall International Mentored Scientist Award
Adaptation of a Male Partner Educational Intervention Tool for Vaginal Microbicide Trials Serah Wagikondi-Gitome, MBChB Fall International Mentored Scientist Award
Evaluation of the Dynamics and Immuno-Virology of Human Papillomavirus Infections among Fishermen in Kisumu, Kenya Raphael Ondondo, PhD Fall International Mentored Scientist Award
Development of a Combination HIV Prevention Intervention for Transgender Women in Peru Alfonso Silva-Santisteban, MD, MPH Fall International Mentored Scientist Award
Optimizing Nevirapine Dosing in Patients Co-infected with Tuberculosis and HIV in Harare, Zimbabwe Luther Gwaza, PhD Spring International Mentored Scientist Award
Examining Sexual Concurrency and Sexual Networks among Married Fishermen Couples in Kisumu District, Kenya Zachary Kwena, PhD(c), MA Fall International Mentored Scientist Award
Family Planning Use Among Female Clients Attending The HIV/AIDS Clinic In Mbarara University Teaching Hospital Winnie Muyindike, MBChB, MMed, DPAM Spring International Mentored Scientist Award
Perioperative Exposure to Blood and Body Fluids: Incidence, Causes and Attitudes in Uganda Timothy Kimuli, MBChB, MMed Spring International Mentored Scientist Award
Frequency and evolution of HIV-1 drug resistance among Ugandan children receiving antiretroviral therapy Jane Achan, MBChB, MMed, MSc Spring International Mentored Scientist Award
Contacts
  • Mechanisms of CD4 T-cell death among HIV-infected, HAART-treated African adults displaying poor CD4 T-cell reconstitution despite effective viral suppression

    Mechanisms of CD4 T-cell death among HIV-infected, HAART-treated African adults displaying poor CD4 T-cell reconstitution despite effective viral suppression

    Headshot of

    Abstract

    Most HIV-infected subjects exhibit a progressive rise in CD4 T-cell counts after initiation of highly active antiretroviral therapy (HAART). However, a subset of individuals exhibit very poor CD4 T cell recovery despite effective control of viremia. Increased activation-induced programmed cell death of CD4 T cells has been proposed as a mechanism underlying poor immune recovery. We propose to perform a nested case control study utilizing a rural cohort of HIV-infected adults whose CD4 T-cell counts have remained low (<50 cell increase) despite HAART for at least six months.

  • Evaluation of the Dynamics and Immuno-Virology of Human Papillomavirus Infections among Fishermen in Kisumu, Kenya

    Evaluation of the Dynamics and Immuno-Virology of Human Papillomavirus Infections among Fishermen in Kisumu, Kenya

    Abstract

    Human papillomavirus (HPV) is associated with cervical, vulvar, anal and penile cancers. High incidence rates of these cancers are observed in Africa compared to other parts of the world. Severa studies have implicated that the sexual behavior of the male partner is or even more important than women?s personal sexual behavior in predicting her risk of HPV associated cancers. Little is known about the natural history of HPV infections among men; thus hampering efforts to control infection in both men and women.

  • Investigation of Pediatric HIV Disclosure in Kampala, Uganda

    Investigation of Pediatric HIV Disclosure in Kampala, Uganda

    Abstract

    There are more than 3 million children 15 years estimated to be living with HIV, with almost 90% residing in sub-Saharan Africa (SSA). This presents a growing challenge to health providers and caregivers concerning the disclosure of HIV serostatus to infected children. Studies conducted in SSA have indicated that only 2% to 37.8% of HIV-infected children 15 years know their HIV status. Despite formal recommendations for disclosure, there are no tested models for supporting caregivers and HIV-infected children in SSA through the process of disclosure.

  • Promoting Positive Caregiver-Child Interaction Between HIV-Affected Children and Their Caregivers with Depression in Kwa-Zulu Natal, South Africa

    Promoting Positive Caregiver-Child Interaction Between HIV-Affected Children and Their Caregivers with Depression in Kwa-Zulu Natal, South Africa

    Abstract

    Depression is a serious public health concern, due to its negative impact of women's health, their infants and their families. HIV-infected caregivers are at high risk for a range of psychiatric and emotional problems that impact medication adherence and disease progression, and negatively affect mother-infant interactions, infant and child health, and development outcomes.

  • Impact of Neonatal Exposure to Malaria and HIV on the Frequency, Phenotype, and Function of __ T Cell Subsets at Birth

    Impact of Neonatal Exposure to Malaria and HIV on the Frequency, Phenotype, and Function of __ T Cell Subsets at Birth

    Abstract

    The Vδ2+ subset of γδ T cells possess intrinsic reactivity to malaria antigens and may be an important antimalarial effector mechanism, but there is evidence that chronic exposure to malaria and HIV is associated with the loss and dysfunction of this subset. It is unclear whether in utero exposure to malaria or HIV is associated with reduced frequencies and/or dysfunction of Vδ 2+ T cells.

  • Feasibility of Screening and Brief Intervention for Hazardous Alcohol use amongst HIV-infected Adults in Uganda: A Qualitative Study

    Feasibility of Screening and Brief Intervention for Hazardous Alcohol use amongst HIV-infected Adults in Uganda: A Qualitative Study

    Headshot of

    Abstract

    In sub-Saharan Africa, screening and brief intervention (SBI) to reduce alcohol consumption may improve HIV treatment outcomes in HIV-infected hazardous drinkers. However, the feasibility, efficacy and effectiveness of this intervention in this region remains unknown. We propose to carry out a qualitative study to describe the feasibility of using SBI to reduce hazardous alcohol use in HIV infected adults in Uganda.